Syukur Berkat Waruwu

Mr. Syukur Berkat Waruwu

Pharmacology, Universitas Sari Mutiara Indonesia, Medan, Sumatera Utara, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ADAminah Dalimunthe
Aminah Dalimunthe
DSDenny Satria
Denny Satria
PSPanal Sitorus
Panal Sitorus
UHUrip Harahap
Urip Harahap
IAIntan Farah Diba Angela
Intan Farah Diba Angela
Syukur Berkat WaruwuSyukur Berkat Waruwu
Syukur Berkat Waruwu
Andaliman (Zanthoxylum acanthopodium DC.) fruit is a spice plant widely used in North Sumatra. The chemical content in the Andaliman plant has a cardioprotective effect, with antioxidant properties that inhibit oxidative stress and free radicals. SOD (superoxide dismutase), BNP (Brain Natriuretic Peptide), and cTnT (troponin T) are measured as markers of heart damage, and histopathology is to see heart damage. Quercetin administration was used as a comparison. The hydroalcoholic extract’s phytochemical content and chemical elements were analyzed using LC-HRMS and GC-MS. The findings showed that the hydroalcohol extract of Andaliman fruits affected the blood levels of SOD, BNP, and cTnT in the blood of doxorubicin-induced rats. SOD levels increased, and BNP decreased; the 300 mg/kg BW group was not significantly different from the 50 mg/kg BW quercetin group. cTnT levels also decreased; the 150 mg/kg BW and 300 mg/kg BW groups were not significantly different, and both were better than the 50 mg/kg BW quercetin group. EAF with 150 mg/kg BW and 300 mg/kg BW can also repair damage to rat heart tissue caused by doxorubicin. Andaliman fruit extract has cardioprotective effects and anti-free radical activity due to its content and potential to be developed.

5 June 2024 in Pharmacia
Verified
Journal Article
Open access
PDF file
PHPoppy Anjelisa Zaitun Hasibuan
Poppy Anjelisa Zaitun Hasibuan
RSRasme Kita Uli Arihta Br Sitorus
Rasme Kita Uli Arihta Br Sitorus
AHAdam Hermawan
Adam Hermawan
FHFathul Huda
Fathul Huda
Syukur Berkat WaruwuSyukur Berkat Waruwu
Syukur Berkat Waruwu
DSDenny Satria
Denny Satria
Vernonia amygdalina Delile, coming from the Asteraceae tribe, contains active compounds that can treat breast cancer. This study examines the anticancer activity of Vernonia amygdalina Delile leaves, an active fraction of MCF-7/HER-2 breast cancer cells. Thin-layer chromatography determines the phytochemical screening. Cytotoxic and proliferation analyses were determined using the MTT method for the MCF-7/HER-2 breast cancer cell line. The cell cycle and apoptosis profiles were examined using flow cytometry. The results can be summarized in this study: Vernonia amygdalina Delile fraction contains a flavonoid with great potential for pharmacological activities, for instance, inhibiting the growth of cancer cells. The ethyl acetate fraction was more potent and cytotoxic on MCF-7/HER-2 cells (IC50 = 66 μg/mL) than extract ethanol (IC50 = 130 μg/mL). The ethylacetate fraction of Vernonia amygdalina Delile has been proven to inhibit cell proliferation by decreasing cell viability with an IC50 of 66 μg/mL concentration incubated for 24, 48, and 72 hrs with cell viability values of 64.46%, 61.67%, and 53.89%, respectively, compared to the ethanol extract IC50 of 130 μg/mL concentration with cell viability values of 56.0%, 50.19%, and 58.67%, respectively, which induced apoptosis and inhibited the cell cycle in the G2-M phase. To conclude, the ethyl acetate fraction of Vernonia amygdalina Delile can be used as an anticancer against the MCF-7/HER-2 cell line with an IC50 of 66 μg/mL, inhibiting cell proliferation and the cell cycle and inducing apoptosis activity in the MCF-7/HER-2 cell.

1 March 2023 in F1000Research
Verified
Journal Article
Open access
PDF file
DSDenny Satria
Denny Satria
ADAminah Dalimunthe
Aminah Dalimunthe
DPDewi Pertiwi
Dewi Pertiwi
MMMahatir Muhammad
Mahatir Muhammad
VKVera Estefania Kaban
Vera Estefania Kaban
Syukur Berkat WaruwuSyukur Berkat Waruwu
Syukur Berkat Waruwu
Background: The use of herbal plants is adopted as a traditional medicine because of their minimal side effects. Most plants have bioactive ingredients and nutritional content that can potentially be used as treatments. One plant that has the potential to be a source of modern medicine is Zanthoxylum acanthopodium DC. Historically the use of traditional medicine as a treatment has enjoyed a good sense of trust among the public. The purpose of this study was to perform a qualitative phytochemical screening and proximate analysis of samples of Zanthoxylum acanthopodium DC. Methods: Used in this study were the phytochemical screening test using the thin-layer chromatography method and the proximate analysis using the AOAC method, which included measuring the ash, water, carbohydrate, total fat, protein, and crude fiber content of the samples. Hydrodistillation was used to isolate volatile oil from the sample, which was then identified using gas chromatography-mass spectrometry. The research method used is experimental. Results: From the test, it was found that the phytochemical content of Zanthoxylum acanthopodium DC is alkaloids, flavonoids, tannins, saponins, glycosides, steroids, and triterpenoids. Proximate analysis obtained ash content of 6.19%, water content of 6.35%, carbohydrates of 35.4%, total fat of 2.46%, protein of 16.2%, and crude fiber of 33.4%. Mineral test results prove that Zanthoxylum acanthopodium DC contains Pb (<0.07 mg/Kg), Cd (<0.03 mg/Kg), As (<0.03 mg/Kg), Hg (0.0011 mg/Kg), Mn (43.1 mg/Kg), K (321 mg/Kg), Ca (0.22 mg/Kg), Mg (198 mg/Kg), Fe (52.1 mg/Kg), and Na (23.6 mg/Kg). The highest content of essential oil in Zanthoxylum acanthopodium DC is geranyl acetate, with a concentration of 24.26%. Conclusions: This study concludes that the research findings of Zanthoxylum acanthopodium DC indicate that the phytochemical, mineral, and volatile oil content of the sample is strongly related to its potential to be developed as food and medicine.

4 October 2022 in Pharmacia
Verified
Journal Article
Open access
PDF file
DSDenny Satria
Denny Satria
Syukur Berkat WaruwuSyukur Berkat Waruwu
Syukur Berkat Waruwu
YYYuandani Yuandani
Yuandani Yuandani
HPHari Purnomo
Hari Purnomo
UHUrip Harahap
Urip Harahap
Objectives: This study aims to determine the protein expression of IL-6, IL-1β, TNF-α, and COX-2 using an immunohistochemistry method based on the anti-inflammatory activity of intraplantar carrageenan solution in male rat paws. Materials and methods: Animals were provided with 1.3 bis(p-Hydroxyphenyl)urea at 12.5, 25, 50, 100, and 200 mg/kg BW. This was administered approximately one hour before the 1% carrageenan induction. As a control measure, diclofenac sodium and CMC sodium 0.5% was similarly administered. After 360 mins, all of the rats were sacrificed, and the inflammatory tissue in the rat’s paw was acquired. The immunohistochemistry preparations were carried out to observe the expression of IL-6, IL-1β, TNF-α, and COX-2. Results: The result showed a decrease in the expression of IL-6, IL-1β, TNF-α, and COX-2, all groups given 1.3 bis(p-Hydroxyphenyl)urea and diclofenac sodium compared to the control group CMC sodium 0.5% CMC sodium 0.5%. From the results of the mean difference test, it can be seen that the IL-1β expression at doses of 50, 100, and 200 mg/Kg BW was not significantly different from that of diclofenac sodium (p > 0.05). Meanwhile, the expression of COX-2, TNF-α, and IL-6 at doses of 100 and 200 mg/Kg BW was not significantly different from that of diclofenac sodium (p > 0.05). Conclusion: The 1.3 bis(p-Hydroxyphenyl)urea has anti-inflammatory activity by decreasing the percentage of IL-6, IL-1β, TNF-α, and COX-2 protein expression in rat’s paw inflammation tissue.

20 September 2022 in F1000Research
Verified
Journal Article
Open access
PDF file
Syukur Berkat WaruwuSyukur Berkat Waruwu
Syukur Berkat Waruwu
UHUrip Harahap
Urip Harahap
YYYuandani Yuandani
Yuandani Yuandani
HPHari Purnomo
Hari Purnomo
DSDenny Satria
Denny Satria
Background: Inflammation is a normal protective response caused by tissue damage through physical trauma, chemical damage, or invasion of pathogenic microorganisms. 1,3-bis(p-hydroxyphenyl)urea is a modified p-aminophenol compound, which is considered to have strong analgesic activity based on cyclooxygenase-2 inhibition and has fewer hepatotoxic side effects. In-silico test showed 1,3-bis(p-hydroxyphenyl)urea has COX-1 and TNF- binding activity, so it has the potential to be developed as an anti-inflammatory agent. Anti-inflammatory activity was tested using mice. Toxicity test was conducted to test the safety of 1,3-bis(p-hydroxyphenyl)urea. Methods: Anti-inflammatory test was carried out by measuring the percentage of inflammation in rat paws using a plethysmometer after administration of 1,3-bis(p-hydroxyphenyl)urea induced by carrageenan 1%, and then histology was performed to observe the number of neutrophils. A toxicity test using OECD guidelines carried out acute toxicity for 24 hours and was observed for 14 days. The subchronic toxicity test was carried out for 28 days, followed by 42 days in the satellite group. Results: Analysis of rat paw inflammation volume showed 1,3-bis(p-hydroxyphenyl)urea could suppress inflammation after carrageenan-1% induction. The group given {1.3 bis (p-Hydroxyphenyl)urea} and sodium diclofenac 2.25 mg/kg BW had a significant difference in results (p0.05) with diclofenac sodium. The number of neutrophils also decreased compared to the 0.5% Na CMC group. The acute toxicity test of 1,3-bis(p-hydroxyphenyl)urea did not cause toxic symptoms and death up to a dose of 5000 mg/kg BW. The microscopic results of subchronic toxicity of liver tissue experienced hydropic degeneration at a dose of 1000 mg/kg BW; in the lungs causes congestion, and microscopic renal tissue undergoes Bowman space dilatation and tubular lumen dilatation, but this condition is reversible. Conclusion: This 1,3-bis(p-hydroxyphenyl)urea compound had an anti-inflammatory activity and relatively low toxicity.

25 March 2024 in Pharmacia
Verified
Journal Article
Open access
PDF file
DSDenny Satria
Denny Satria
PSPanal Sitorus
Panal Sitorus
ADAminah Dalimunthe
Aminah Dalimunthe
Syukur Berkat WaruwuSyukur Berkat Waruwu
Syukur Berkat Waruwu
VAVivi Asfianti
Vivi Asfianti
Many medicinal plants are now being chosen because the treatment is safer and cheaper.Artocarpus lacuchaBuch-Ham is a plant with many pharmacological activities and is efficacious; its safety has not been studied. Acute oral toxicity evaluation followed Organization for Economic Co-operation and Development guidelines using the fixed dose method. The evaluation began with a preliminary test, then a primary test with three groups: a 2000 mg/Kg BW dose test group, a 5000 mg/Kg BW dose test group, and a control group. The results of visual observations, haematological and clinical examinations, and histological examination of organs (liver, spleen, kidneys, lungs and heart) showed no toxicity in the animals, and they did not die during testing. The findings of this study support the safety ofArtocarpus lacuchaBuch-Ham leaf ethanol extract, which did not produce harmful results in acute toxicity tests.